United States · Who invested in Wereworld Therapeutics?
Wereworld Therapeutics's investors include MPM Capital, Longwood Fund, Taiho Ventures, UPMC Enterprises and Arkin Bio Ventures. MPM Capital led its latest round.
United States · Series A startup
Who invested in Wereworld Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$56Mraised across 1 round since 2019, from 1 source
- Latest round
- Series A, $56MNov 2019
- Led by
- MPM Capital and Longwood Fund
- Investors
- 5 (2 led)
The rounds
- Nov 2019Series A$56M
MPM CapitalLead
Longwood FundLead- Taiho Ventures
UPMC Enterprises- Arkin Bio Ventures
Reported by FinSMEs
Everyone who backed them
Taiho VenturesCorporate VC1round
Arkin Bio Venturesno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Wereworld Therapeutics
How much has Wereworld Therapeutics raised?
Wereworld Therapeutics has raised $56M across 1 round since 2019.
When did Wereworld Therapeutics last raise?
Wereworld Therapeutics's most recent round was a Series A of $56M in Nov 2019, led by MPM Capital.
What was Wereworld Therapeutics's biggest round?
Its most recent round, $56M in Nov 2019, is also its largest on record.
Who backed Wereworld Therapeutics first?
Wereworld Therapeutics's first round on record, in Nov 2019, was backed by MPM Capital, Longwood Fund and Taiho Ventures and 2 others.
What stage is Wereworld Therapeutics at?
Wereworld Therapeutics's latest named round is a Series A, in Nov 2019.
Where is Wereworld Therapeutics based?
Wereworld Therapeutics is based in the United States.
Who led Wereworld Therapeutics's rounds?
MPM Capital led the Series A in 2019.
Companies like Wereworld Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.